Process for the manufacture of thrombin inhibitors

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

195/1.2, 195/1.3

C12N 15/15 (2006.01) A61K 38/58 (2006.01) C07H 21/00 (2006.01) C07K 14/815 (2006.01) C07K 16/38 (2006.01) C12N 1/19 (2006.01) C12N 1/21 (2006.01) C12N 15/10 (2006.01) C12N 15/74 (2006.01) C12N 15/81 (2006.01)

Patent

CA 1341426

The invention relates to DNA sequences that code for the amino acid sequence of the thrombin inhibitor hirudin, hybrid vectors containing such DNA sequences, host cells transformed with such hybrid vectors, novel polypeptides with thrombin-inhibiting activity produced from such transformed host cells, processes for the manufacture of these DNA sequences, hybrid vectors and transformed host cells, and processes for the manu- facture of these thrombin-inhibitors using the trans- formed host cells. The hirudin compounds that can be produced according to the invention have valuable pharmacological properties.

483736

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Process for the manufacture of thrombin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for the manufacture of thrombin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the manufacture of thrombin inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1268117

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.